Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers

Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research
AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers ( Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research )
1 May 2009

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009

Myelodysplastic Syndromes and Acute Myeloid Leukaemia

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Myelodysplastic Syndromes and Acute Myeloid Leukaemia ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

How azacitidine works

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
How azacitidine works ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

Effects of Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

Azacitidine for Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version
ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )
16 Feb 2009

Clinical research needs better interpretation

Professor Aron Goldhirsch, Director of the Department of Medicine at the European Institute of Oncology
Clinical research needs better interpretation ( Professor Aron Goldhirsch, Director of the Department of Medicine at the European Institute of Oncology )
12 Jan 2009

Extrapolating info from clinical trials to individual patients

Professor Richard Gelber, Biostatistics and Computational Biology, Dana-Farber Cancer Institute
Extrapolating info from clinical trials to individual patients ( Professor Richard Gelber, Biostatistics and Computational Biology, Dana-Farber Cancer Institute )
12 Jan 2009

Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer Symposium

Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the Institute of Cancer Research
Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer Symposium ( Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the Institute of Cancer Research )
9 Jan 2009

Endoxifen levels in Breast Cancer patients and testing for CYP2D6

Dr John Hawse, Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine
Endoxifen levels in Breast Cancer patients and testing for CYP2D6 ( Dr John Hawse, Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine )
9 Jan 2009

Prince of Wales Hospital, Australia

Prof. Michael Friedlander
Prince of Wales Hospital, Australia ( Prof. Michael Friedlander )
3 Dec 2008

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation